Publisher
Springer Berlin Heidelberg
Reference37 articles.
1. Arzneimittelkommission der Deutschen Ärzteschaft (2001): Empfehlungen zur Therapie der Demenz. Arzneiverordnung in der Praxis, Sonderheft, 2.
2. Auflage. Bickel H. (2000): Dementia syndrome and Alzheimer disease: an assessment of morbidity and annual incidence in Germany. Gesundheitswesen 62: 211–218.
3. Birks J., Iakovidou V., Tsolaki M. (2000): Rivastigmine for Alzheimer’s disease. Cochrane Database Syst. Rev. 2: CD001191.
4. Birks J.S., Melzer D., Beppu H. (2002): Donepezil for mild and moderate Alzheimer’s disease (Cochrane-Review). The Cochrane Library, Issue 2, 2002, Oxford: Updated Software.
5. Birmingham K., Frantz S. (2002): Set back to Alzheimer vaccine studies. Nat. Med. 8: 199–200.